PROTAGONIST THERAPEUTICS
Live / Allowed — Fifth extension granted (statement of use) (as of 22 Jul 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 03 Mar 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 97822178
- Mark type
- Word mark
- Filed
- 03 Mar 2023
- Published for opposition
- 29 Aug 2023
- Attorney of record
- Melissa A. Nowak
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for use in the treatment of cancer and blood diseases and disorders; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for the treatment of metabolic disorders
- Class 042 — Scientific and technological services: Medical research and medical research information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders; Scientific research, pharmaceutical research, medical research; technical consultation services in the field of research and product development for the treatment of immune mediated diseases, inflammatory diseases, oncological disorders and rare diseases; scientific consultation services in the fields of immune mediated diseases, inflammatory diseases, oncological disorders and rare diseases; product development services for others in the fields of immune mediated diseases, inflammatory diseases, oncological disorders and rare diseases; research and development of new products pertaining to the treatment of immune mediated diseases, inflammatory diseases, oncological and rare diseases
- Class 044 — Medical, beauty and agricultural services: Providing healthcare information to healthcare professionals and patients relating to disease states and treatment options; Medical information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders
Owner
- PROTAGONIST THERAPEUTICS, INC., Newark, CA, US
- PROTAGONIST THERAPEUTICS, INC., Newark, CA, US
Prosecution history
- 23 Jul 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Jul 2026 — SOU EXTENSION 5 GRANTED
- 12 Mar 2026 — SOU EXTENSION 5 FILED
- 22 Jul 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 09 Dec 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 09 Dec 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 Dec 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 09 Dec 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 23 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Oct 2025 — SOU EXTENSION 4 GRANTED
- 20 Oct 2025 — SOU EXTENSION 4 FILED
- 20 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 16 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Apr 2025 — SOU EXTENSION 3 GRANTED